MedPath

on randomized trial to compare efficacy of tolvaptan and trichlormethiazide in adult congenital heart disease

Not Applicable
Recruiting
Conditions
adult congenital heart disease
Registration Number
JPRN-UMIN000018009
Lead Sponsor
Tokyo Women's Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

1.Ventricular assist device 2.Complicated with low cardiac output syndrome, HCM, under inotrope infusion, and hepatic coma. 3. Aneuria or uncontrolled diabetes.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality in 6 month, rate and frequency of re-admission, urine osmolity and sodium concentration, serum electrolytes
Secondary Outcome Measures
NameTimeMethod
body weight, sign of congestion, side effects
© Copyright 2025. All Rights Reserved by MedPath